Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 636

1.

Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance.

Vgontzas AN, Bixler EO, Chrousos GP.

J Intern Med. 2003 Jul;254(1):32-44. Review.

2.

Sleep apnea is a manifestation of the metabolic syndrome.

Vgontzas AN, Bixler EO, Chrousos GP.

Sleep Med Rev. 2005 Jun;9(3):211-24. Review.

PMID:
15893251
3.
4.

Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea.

Vgontzas AN, Trakada G, Bixler EO, Lin HM, Pejovic S, Zoumakis E, Chrousos GP, Legro RS.

Metabolism. 2006 Aug;55(8):1076-82.

PMID:
16839844
5.

Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance.

Vgontzas AN, Legro RS, Bixler EO, Grayev A, Kales A, Chrousos GP.

J Clin Endocrinol Metab. 2001 Feb;86(2):517-20.

PMID:
11158002
6.

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome.

Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP.

Eur Heart J. 2004 May;25(9):735-41.

7.

Insulin resistance and daytime sleepiness in patients with sleep apnoea.

Barceló A, Barbé F, de la Peña M, Martinez P, Soriano JB, Piérola J, Agustí AG.

Thorax. 2008 Nov;63(11):946-50. doi: 10.1136/thx.2007.093740.

PMID:
18535117
8.

Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.

Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T.

Clin Endocrinol (Oxf). 2006 Jan;64(1):12-9.

PMID:
16402923
9.

Obesity-related sleepiness and fatigue: the role of the stress system and cytokines.

Vgontzas AN, Bixler EO, Chrousos GP.

Ann N Y Acad Sci. 2006 Nov;1083:329-44. Review.

PMID:
17148748
10.

Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables.

Tassone F, Lanfranco F, Gianotti L, Pivetti S, Navone F, Rossetto R, Grottoli S, Gai V, Ghigo E, Maccario M.

Clin Endocrinol (Oxf). 2003 Sep;59(3):374-9.

PMID:
12919162
11.

Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.

Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Sancho J, San Millán JL.

Diabetologia. 2003 May;46(5):625-33.

PMID:
12739017
12.

Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia.

Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP.

J Clin Endocrinol Metab. 2000 Mar;85(3):1151-8.

PMID:
10720054
13.

Structural equation modeling of sleep apnea, inflammation, and metabolic dysfunction in children.

Waters KA, Mast BT, Vella S, de la Eva R, O'Brien LM, Bailey S, Tam CS, Wong M, Baur LA.

J Sleep Res. 2007 Dec;16(4):388-95.

14.

Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea.

Bonsignore MR, Esquinas C, Barceló A, Sanchez-de-la-Torre M, Paternó A, Duran-Cantolla J, Marín JM, Barbé F.

Eur Respir J. 2012 May;39(5):1136-43. doi: 10.1183/09031936.00151110.

15.

Obesity and sleep disturbances: meaningful sub-typing of obesity.

Vgontzas AN, Bixler EO, Chrousos GP, Pejovic S.

Arch Physiol Biochem. 2008 Oct;114(4):224-36. doi: 10.1080/13813450802521507 . Review.

PMID:
18946783
16.

Childhood obesity, adipose tissue distribution, and the pediatric practitioner.

Slyper AH.

Pediatrics. 1998 Jul;102(1):e4. Review.

PMID:
9651456
17.

Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.

Alam I, Lewis K, Stephens JW, Baxter JN.

Obes Rev. 2007 Mar;8(2):119-27. Review.

PMID:
17300278
18.

Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.

Wehr E, Möller R, Horejsi R, Giuliani A, Kopera D, Schweighofer N, Groselj-Strele A, Pieber TR, Obermayer-Pietsch B.

Wien Klin Wochenschr. 2009;121(7-8):262-9. doi: 10.1007/s00508-009-1162-2.

PMID:
19562283
19.
20.

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.

Clin Endocrinol (Oxf). 2004 Dec;61(6):738-46.

PMID:
15579189
Items per page

Supplemental Content

Support Center